請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33023完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 林榮耀 | |
| dc.contributor.author | Yen-Han Lai | en |
| dc.contributor.author | 賴彥翰 | zh_TW |
| dc.date.accessioned | 2021-06-13T04:22:16Z | - |
| dc.date.available | 2006-08-04 | |
| dc.date.copyright | 2006-08-04 | |
| dc.date.issued | 2006 | |
| dc.date.submitted | 2006-07-23 | |
| dc.identifier.citation | 1.Lam, J.S., et al., Role of molecular markers in the diagnosis and therapy of renal cell carcinoma. Urology, 2005. 66(5, Supplement 1): p. 1-9.
2.Jones, J., et al., Gene Signatures of Progression and Metastasis in Renal Cell Cancer. Clin Cancer Res, 2005. 11(16): p. 5730-5739. 3.Atkins, D., R. Lichtenfels, and B. Seliger, Heat shock proteins in renal cell carcinomas. Contrib Nephrol, 2005. 148: p. 35-56. 4.Tang, S.W., et al., Identification of differentially expressed genes in clear cell renal cell carcinoma by analysis of full-length enriched cDNA library. J Biomed Sci, 2006: p. 1-8. 5.Ozaki, T. and S. Sakiyama, Molecular cloning of rat calpactin I heavy-chain cDNA whose expression is induced in v-src-transformed rat culture cell lines. Oncogene, 1993. 8(6): p. 1707-10. 6.Jindal, H.K., et al., The protein-tyrosine kinase substrate, calpactin I heavy chain (p36), is part of the primer recognition protein complex that interacts with DNA polymerase alpha. J Biol Chem, 1991. 266(8): p. 5169-76. 7.Chiang, Y., et al., Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol Cell Biochem, 1999. 199(1-2): p. 139-47. 8.Frohlich, M., et al., Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. Mol Cell Biol, 1990. 10(6): p. 3216-23. 9.Vishwanatha, J.K., et al., Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis, 1993. 14(12): p. 2575-2579. 10.Reeves, S.A., et al., Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma. Cancer Res, 1992. 52(24): p. 6871-6876. 11.Emoto, K., et al., Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res, 2001. 21(2B): p. 1339-45. 12.Menell, J.S., et al., Annexin II and Bleeding in Acute Promyelocytic Leukemia. N Engl J Med, 1999. 340(13): p. 994-1004. 13.Maines, M.D., et al., Nuclear Localization of Biliverdin Reductase in the Rat Kidney: Response to Nephrotoxins That Induce Heme Oxygenase-1. J Pharmacol Exp Ther, 2001. 296(3): p. 1091-1097. 14.Cruse, I. and M.D. Maines, Evidence suggesting that the two forms of heme oxygenase are products of different genes. J. Biol. Chem., 1988. 263(7): p. 3348-3353. 15.McCoubrey, J.W.K., J.F. Ewing, and M.D. Maines, Human heme oxygenase-2: Characterization and expression of a full-length cDNA and evidence suggesting that the two HO-2 transcripts may differ by choice of polyadenylation signal. Archives of Biochemistry and Biophysics, 1992. 295(1): p. 13-20. 16.McCoubrey, W.K., Jr., T.J. Huang, and M.D. Maines, Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem, 1997. 247(2): p. 725-732. 17.Otterbein, L.E. and A.M. Choi, Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol, 2000. 279(6): p. L1029-37. 18.Brouard, S., et al., Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis. J. Exp. Med., 2000. 192(7): p. 1015-1026. 19.Otterbein, L.E., et al., Heme oxygenase-1: unleashing the protective properties of heme. Trends in Immunology, 2003. 24(8): p. 449-455. 20.Sedlak, T.W. and S.H. Snyder, Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics, 2004. 113(6): p. 1776-82. 21.Baranano, D.E., et al., A Mammalian Iron ATPase Induced by Iron. J. Biol. Chem., 2000. 275(20): p. 15166-15173. 22.Melo, L.G., et al., Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation, 2002. 105(5): p. 602-7. 23.Katori, M., R.W. Busuttil, and J.W. Kupiec-Weglinski, Heme oxygenase-1 system in organ transplantation. Transplantation, 2002. 74(7): p. 905-12. 24.Kim, J.H., et al., Heme Oxygenase-1 Protects Rat Kidney from Ureteral Obstruction via an Antiapoptotic Pathway. J Am Soc Nephrol, 2006. 17(5): p. 1373-1381. 25.Maines, M.D. and P.-A. Abrahamsson, Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution. Urology, 1996. 47(5): p. 727-733. 26.Liu, Z.M., et al., Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene, 2004. 23(2): p. 503-13. 27.Tsuji, M.H., et al., Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis. Cancer Letters, 1999. 138(1-2): p. 53-59. 28.Berberat, P.O., et al., Inhibition of Heme Oxygenase-1 Increases Responsiveness of Pancreatic Cancer Cells to Anticancer Treatment. Clin Cancer Res, 2005. 11(10): p. 3790-3798. 29.Mayerhofer, M., et al., Identification of Heme Oxygenase-1 As a Novel BCR/ABL-Dependent Survival Factor in Chronic Myeloid Leukemia. Cancer Res, 2004. 64(9): p. 3148-3154. 30.Goodman, A.I., et al., Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc Soc Exp Biol Med, 1997. 214(1): p. 54-61. 31.Flad, T., et al., T cell epitope definition by differential mass spectrometry: identification of a novel, immunogenic HLA-B8 ligand directly from renal cancer tissue. Proteomics, 2006. 6(1): p. 364-74. 32.Sunamura, M., et al., Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis, 2003. 6(1): p. 15-24. 33.Chen, G.G., et al., Heme oxygenase-1 protects against apoptosis induced by tumor necrosis factor-alpha and cycloheximide in papillary thyroid carcinoma cells. J Cell Biochem, 2004. 92(6): p. 1246-56. 34.Kushida, T., et al., A significant role for the heme oxygenase-1 gene in endothelial cell cycle progression. Biochem Biophys Res Commun, 2002. 291(1): p. 68-75. 35.Abraham, N.G., G. Scapagnini, and A. Kappas, Human heme oxygenase: cell cycle-dependent expression and DNA microarray identification of multiple gene responses after transduction of endothelial cells. J Cell Biochem, 2003. 90(6): p. 1098-111. 36.Ryter, S.W., J. Alam, and A.M.K. Choi, Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications. Physiol. Rev., 2006. 86(2): p. 583-650. 37.Kim, H.P., et al., Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J., 2004. 18(10): p. 1080-1089. 38.Li Volti, G., et al., Immunocytochemical localization and expression of heme oxygenase-1 in primary astroglial cell cultures during differentiation: effect of glutamate. Biochemical and Biophysical Research Communications, 2004. 315(2): p. 517-524. 39.Filipenko, N.R., et al., Annexin A2 Is a Novel RNA-binding Protein. J. Biol. Chem., 2004. 279(10): p. 8723-8731. 40.Hofmann, R.M. and C.M. Pickart, Noncanonical MMS2-Encoded Ubiquitin-Conjugating Enzyme Functions in Assembly of Novel Polyubiquitin Chains for DNA Repair. Cell, 1999. 96(5): p. 645-653. 41.Andersen, P.L., et al., Distinct regulation of Ubc13 functions by the two ubiquitin-conjugating enzyme variants Mms2 and Uev1A. J Cell Biol, 2005. 170(5): p. 745-55. 42.Matsuda, A., et al., Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene, 2003. 22(21): p. 3307-18. 43.An, J. and M.B. Rettig, Mechanism of von Hippel-Lindau Protein-Mediated Suppression of Nuclear Factor kappa B Activity. Mol. Cell. Biol., 2005. 25(17): p. 7546-7556. 44.Nishitani, H., et al., Full-sized RanBPM cDNA encodes a protein possessing a long stretch of proline and glutamine within the N-terminal region, comprising a large protein complex. Gene, 2001. 272(1-2): p. 25-33. 45.Mikolajczyk, M., et al., The cyclin-dependent kinase 11p46 isoform interacts with RanBPM. Biochemical and Biophysical Research Communications, 2003. 310(1): p. 14-18. 46.Wang, Y., et al., HIPK2 associates with RanBPM. Biochemical and Biophysical Research Communications, 2002. 297(1): p. 148-153. 47.Hafizi, S., et al., The Ran binding protein RanBPM interacts with Axl and Sky receptor tyrosine kinases. The International Journal of Biochemistry & Cell Biology, 2005. 37(11): p. 2344-2356. 48.Cheng, L., S. Lemmon, and V. Lemmon, RanBPM is an L1-interacting protein that regulates L1-mediated mitogen-activated protein kinase activation. Journal of Neurochemistry, 2005. 94(4): p. 1102-1110. 49.Cao, G., et al., Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol Cell Physiol, 2002. 282(5): p. C1181-1190. 50.O'Brien, C.D., et al., Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration. Am J Physiol Cell Physiol, 2004. 287(4): p. C1103-1113. 51.Gao, C., et al., PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood, 2003. 102(1): p. 169-179. 52.Li Volti, G., et al., Differential effect of heme oxygenase-1 in endothelial and smooth muscle cell cycle progression. Biochemical and Biophysical Research Communications, 2002. 296(5): p. 1077-1082. 53.Peyton, K.J., et al., Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood, 2002. 99(12): p. 4443-4448. 54.Fang, J., et al., In Vivo Antitumor Activity of Pegylated Zinc Protoporphyrin: Targeted Inhibition of Heme Oxygenase in Solid Tumor. Cancer Res, 2003. 63(13): p. 3567-3574. 55.Schneider, B.L. and M. Kulesz-Martin, Destructive cycles: the role of genomic instability and adaptation in carcinogenesis. Carcinogenesis, 2004. 25(11): p. 2033-2044. 56.Tanaka, S. and J.F.X. Diffley, Deregulated G1-cyclin expression induces genomic instability by preventing efficient pre-RC formation. Genes Dev., 2002. 16(20): p. 2639-2649. 57.Spruck, C.H., K.A. Won, and S.I. Reed, Deregulated cyclin E induces chromosome instability. Nature, 1999. 401(6750): p. 297-300. 58.Ekholm-Reed, S., et al., Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J. Cell Biol., 2004. 165(6): p. 789-800. 59.Ylva Hedberg, E.D.B.L.G.R.G.L., Cyclin E and p27 protein content in human renal cell carcinoma: Clinical outcome and associations with cyclin D. International Journal of Cancer, 2002. 102(6): p. 601-607. 60.Ylva, H., et al., Cyclin D3 Protein Content in Human Renal Cell Carcinoma in Relation to Cyclin D1 and Clinico-pathological Parameters. Acta Oncologica, 2002. 41(2): p. 175-181. 61.Kim, H.J., et al., Heme oxygenase-1 attenuates the cisplatin-induced apoptosis of auditory cells via down-regulation of reactive oxygen species generation. Free Radic Biol Med, 2006. 40(10): p. 1810-1819. 62.Petrache, I., et al., Heme oxygenase-1 inhibits TNF-alpha -induced apoptosis in cultured fibroblasts. Am J Physiol Lung Cell Mol Physiol, 2000. 278(2): p. L312-319. 63.Liu, X.M., et al., Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res, 2002. 55(2): p. 396-405. 64.Chao, D.T. and S.J. Korsmeyer, BCL-2 FAMILY: Regulators of Cell Death. Annual Review of Immunology, 1998. 16(1): p. 395-419. 65.Bettaieb, A., et al., Bcl-2 proteins: targets and tools for chemosensitisation of tumor cells. Curr Med Chem Anticancer Agents, 2003. 3(4): p. 307-18. 66.Gautschi, O., et al., Activity of a Novel bcl-2/bcl-xL-Bispecific Antisense Oligonucleotide Against Tumors of Diverse Histologic Origins. J Natl Cancer Inst, 2001. 93(6): p. 463-471. 67.Itoi, T., et al., Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients. Br J Cancer, 2004. 90(1): p. 200-5. 68.Kausch, I., et al., Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma. Eur Urol, 2005. 47(5): p. 703-9. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33023 | - |
| dc.description.abstract | 腎細胞癌佔所有的惡性腫瘤中的百分之二十，也是最致命的一種腎臟癌類型。目前最常見的腎細胞癌類型是透明細胞型，它對於傳統的治療方式具有高度的抗性，所以手術切除是目前主要的治療方式。因此，我們希望藉由研究腎細胞癌相關基因來了解腎細胞癌形成的分子機制。在先前的研究中，本實驗室的唐賽文先生建構了腎細胞癌以及正常腎臟組織的全長cDNA庫，希望藉由比較兩者之間不同基因的表現來找出與腎細胞癌形成的相關基因。經過比較之後，發現Annexin A2 (AnxA2)和Heme oxygenase-1 (HO-1)這兩個基因在腎細胞癌中的表現有上升的情形。
AnxA2是一個由鈣調節和磷酸脂鍵結的蛋白質，在許多的轉型的正常細胞株和癌細胞株中都有發現它的表現量上升的情形。HO-1是一個熱休克蛋白，它能被許多逆境因子誘發。它能催化血基質(heme)的分解，並產生一氧化碳(CO)、膽紅素(bilirubin)，和鐵離子(Fe2+)。HO-1在許多癌症中也都有表現量上升的情形，在某些癌症中則是和血管增生有關。這些結果顯示AnxA2和HO-1對於癌細胞的生長和發展中扮演了非常重要的角色。 在本篇研究中我們發現了AnxA2和HO-1的mRNA和蛋白質在臨床採集的腎細胞癌組織中有表現量上升的情形。而在免疫組織染色的實驗中，我們發現HO-1會進入細胞核。在腎細胞以及腎細胞癌的細胞株中，我們利用共軛焦顯微鏡以及細胞核分離法進一步確認HO-1也會進入細胞核。於是，我們使用酵母菌雙雜合篩選系統來尋找可能在細胞核中與HO-1作用的蛋白質。在功能性的研究中，我們發現在HEK293細胞中過度表現HO-1會造成調控細胞週期G1/S時期相關的蛋白的表現量的上升，另外它也能夠使得細胞能對抗cisplatin所引起的細胞凋亡並且造成bcl-2蛋白質的表現量上升。綜合以上的結果，我們認為在腎細胞癌中過度表現的HO-1不但可以使得細胞比較具有癌化的傾向，而且還能使得細胞對抗抗癌藥物所引起的細胞凋亡。另外，由酵母菌雙雜合篩選系統所找到與HO-1作用的蛋白質中，我們發現HO-1可能會參與細胞核中的訊息傳遞，並且也可能參與NFκB的活化。 | zh_TW |
| dc.description.abstract | Renal cell carcinoma (RCC) accounts for 2% of all adult malignancies and is the most lethal of common urologic cancers. The major type of RCC is clear cell RCC (ccRCC). It is highly resistant to traditional therapies, and surgery remains to be the main method of treatment. Therefore, identification of RCC-associated genes is important in understanding the molecular mechanisms of ccRCC. In previous studies, full-length enriched cDNA libraries of ccRCC and normal kidney tissues were constructed by Mr. Sai-Wen Tang from this laboratory. By comparing the differential gene-expression profiles of ccRCC and normal tissues, Heme oxygenase 1 (HO-1) and Annexin A2 (AnxA2) were found to be up-reglulated in ccRCC tissues.
AnxA2 is a Ca2+-dependent phospholipid binding protein, and its overexpression has been found in virally transformed cell lines and various tumors. HO-1 is a heat shock protein induced by a variety of stress stimuli. HO-1 catalyzes the degradation of heme to produce CO, biliverdin, and Fe2+. Elevated HO-1 expression was found in various tumors and linked to angiogenesis in some tumors. These findings suggest that HO-1 and AnxA2 might play a crucial role in tumor development and progression. In present study, the expression of HO-1 and AnxA2 genes were found up-regulated in mRNA as well as protein levels of ccRCC tissue pairs. Immunohistochemical studies showed that HO-1 localized in the nucleus in ccRCC tissues, and this was further confirmed in kideney and RCC cell lines by confocal microscopy and subcellular fractionation. Therefore, yeast two-hybrid was performed to identify HO-1 interacting proteins in the nucleus. By functional studies, we have demonstrated that overexpression of HO-1 in HEK293 cell line induced the up-regulation of several G1/S cell cycle regulatory genes, and it also protected cells from cisplatin induced apoptosis and up-regulated protein levels of bcl-2. Taken together, it is suggested that overexpression of HO-1 in ccRCC could provide a selective advantage towards cell transformation, and protect cells from cisplatin- induced apoptosis. Furthermore, the identification of putative HO-1 binding proteins by yeast two-hybrid suggested that HO-1 might participate in cell signaling in the nucleus and also the activation of the NFκB pathway. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T04:22:16Z (GMT). No. of bitstreams: 1 ntu-95-R93442024-1.pdf: 3740832 bytes, checksum: 2f5069680096f3291739a5e55f2824e6 (MD5) Previous issue date: 2006 | en |
| dc.description.tableofcontents | Table of contents..............1
Abbreviations..................2 摘要...........................3 Abstract.......................5 Introduction...................7 Materials and methods..........12 Results........................37 Discussion.....................46 Figures........................55 Legends........................66 References..........73 | |
| dc.language.iso | en | |
| dc.subject | 腎細胞癌 | zh_TW |
| dc.subject | HO-1 | en |
| dc.subject | Annexin A2 | en |
| dc.subject | RCC | en |
| dc.title | 腎細胞癌相關基因Heme oxygenase-1與Annexin A2之功能性研究 | zh_TW |
| dc.title | Studies on the function of RCC-associated genes, Heme oxygenase-1 and Annexin A2 | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 94-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 錢宗良,吳華林,周玉山 | |
| dc.subject.keyword | 腎細胞癌, | zh_TW |
| dc.subject.keyword | RCC,HO-1,Annexin A2, | en |
| dc.relation.page | 77 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2006-07-23 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 生物化學暨分子生物學研究所 | zh_TW |
| 顯示於系所單位： | 生物化學暨分子生物學科研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-95-1.pdf 未授權公開取用 | 3.65 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。